Keywords:
SARS-Cov-2; immunology; covid-19; epidemiology; antibodies; viral; seroepidemiologic studies; cross-sectional studies
Abstract:
Following reduction of public health and social measures concurrent with SARS-CoV-2 Omicron emergence in late 2021 in Australia, COVID-19 case notification rates rose rapidly. As rates of direct viral testing and reporting dropped, true infection rates were most likely to be underestimated.